跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALEVE NIGHTTIME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ALEVE NIGHTTIME
Authorized
STANDARD
ALEVE NIGHTTIME
Bayer Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5fd2ca78b4b1de8f
Company
Bayer Inc
Type
Standard
Approval Details
Approval Id
5fd2ca78b4b1de8f
Drug Approval Canada Name
ALEVE NIGHTTIME
Product Name
ALEVE NIGHTTIME
Status
Marketed
Status Date
2016-02-24
Original Market Date
2016-02-24
Din
02444593
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE02 NAPROXEN
Atc Name
m 01 ae 02
Aig Number
0257270001
Company Name
Bayer Inc
Company Address
2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6
Active Ingredients
NAPROXEN SODIUM
220 MG
DIPHENHYDRAMINE HYDROCHLORIDE
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5fd2ca78b4b1de8f
Type
Standard
Back to Health Canada Approvals